In biopharmaceutical manufacturing, even the most unassuming components can pose outsized risks. Chromatography and synthesis column seals—critical to process integrity—are often subject to one-size-fits-all maintenance schedules that overlook their specific operating environments. This article explores how risk-based frameworks, per-batch changeover strategies, and modern condition monitoring tools can be used to tailor seal replacement protocols for greater efficiency, reliability, and regulatory compliance.
The hidden risk in plain sight
In a production environment defined by precision, the failure of a single seal can derail an entire batch—resulting in contamination, downtime, or regulatory noncompliance. While seals are essential to maintaining system integrity and sterility, their maintenance is often governed by outdated policies rooted in habit, rather than data. With increasing pressure to maximize uptime, contain costs, and comply with stringent GMP standards, manufacturers are rethinking their approach. A risk-based strategy—grounded in process-specific conditions and real-time data—offers a more intelligent path forward.
Rethinking routine: risk assessment frameworks for seal change frequency
Traditional time-based maintenance models assume all seals degrade at the same rate. However, in practice, each seal’s life cycle depends on its exposure to stress, materials, and process criticality.
Risk assessment frameworks—such as those aligned with ICH Q9 guidelines—allow manufacturers to classify seals based on:
- Material compatibility (e.g., exposure to solvents, pH extremes)
- Mechanical and thermal stress (e.g., high-pressure operations)
- Contact with drug substance or product intermediates
- Historical performance and failure rates
- Role in sterile or critical paths
Many manufacturers adopt risk-informed standard operating procedures that guide seal replacement schedules. For higherrisk applications, seals may be changed after every batch. In lower-risk scenarios, replacements might be scheduled per production campaign or at defined intervals based on insights from tools like FMEA or root cause analysis.
By assessing seals based on risk level—high, medium, or low—manufacturers can take a more strategic, data-driven approach to maintenance. High-risk seals may require replacement after each run, while others can be managed by condition or usage. This not only reduces unnecessary part changes and production delays, but also strengthens compliance by providing documented rationale for seal management decisions.
Artificial intelligence (AI) further plays a transformative role in risk assessment across pharmaceutical manufacturing. According to a 2024 study, AI enhances risk framework development by enabling “systematic integration of model risk and process knowledge,” improving decision-making in both model validation and lifecycle management. This approach allows manufacturers to anticipate potential process failures and quality issues with greater accuracy and speed, embedding a deeper layer of intelligence into modern Quality by Design (QbD) strategies.
Overall, insights signal a broader industry shift toward formalized, evidence-based decision-making in equipment lifecycle management—especially critical when determining seal change frequencies and maintenance protocols.
When a per-batch changeover still makes sense
While risk-based protocols offer efficiency, per-batch seal replacement remains important in certain contexts—especially where the margin for error is effectively zero.
Common scenarios requiring batch-level changeovers include:
- Demanding and high stress manufacturing processes that may compromise seals due to
extreme heat, pressure, chemical exposure, or mechanical and thermal stress (e.g., highpressure operations) - High-potency or personalized therapies such as CAR-T cells or antibody-drug conjugates
(ADCs) - Single-use systems or processes designed with closed-loop configurations
- Manufacturing steps under heightened regulatory oversight requiring strict process
controls
In these settings, a per-batch model mitigates risks of cross-contamination, simplifies documentation, and aligns with regulatory expectations. It also reduces reliance on post-use inspection, which may not detect internal or microscopic seal degradation.
Per-batch replacement isn’t just a safety net—it’s a compliance tool. The practice demonstrates a facility’s commitment to quality, traceability, and patient safety, especially in therapies with narrow therapeutic indices or high-risk patient populations.
Condition-based maintenance: tools for monitoring seal integrity
For seals that do not require per-batch replacement, condition-based maintenance—supported by modern monitoring tools—provides a path to both reliability and efficiency.
Key monitoring techniques include:
1. Visual inspection
Routine visual checks by trained technicians can identify cracks, deformation, swelling, or chemical attack. While widely used, visual inspections alone may miss early-stage or internal damage.
2. Pressure testing
Pressure decay or bubble testing can reveal micro-leaks that compromise seal integrity. Particularly useful in high-pressure systems or pre-sterilized assemblies, this method provides a more objective validation.
3. Torque and compression measurements
Monitoring torque during seal installation and measuring compression set can flag seals that are losing elasticity or deviating from specification—early indicators of wear.
4. Sensor-enabled monitoring
Temperature, pressure, and cycle-count sensors embedded in process equipment offer predictive insights. When integrated with MES or SCADA platforms, these inputs enable alerts for preemptive seal changes before failure occurs.
5. Historical data logging and trend analysis
Logging seal installation dates, lot numbers, and replacement frequency in electronic batch records (EBRs) allows teams to analyze trends and optimize replacement intervals over time. Together, these strategic actions enable a predictive maintenance model—where seals are replaced not by schedule or guesswork, but based on actual wear and usage conditions.
Precision starts with preventionPrecision starts with prevention
A proactive, risk-based approach to column seal maintenance safeguards both product integrity and operational efficiency. By leveraging data, prioritizing critical components and embracing smart monitoring tools, manufacturers can minimize downtime, prevent failures, and maintain compliance—ensuring seals never become the weak link in an otherwise robust biomanufacturing process.